Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | GAA | P10253 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.39 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.39 |
| ▸ | ERN1 | O75460 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.38 |
| ▸ | DAO | P14920 | 1/20 | 0.38 |
| ▸ | DDO | Q99489 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18000155 | 0.81 | KDM4E (0.38) | KDM4EGAAALDH1A1SMN1; SMN2HTT | |
| SCHEMBL12777896 | 0.79 | CYP2A6 (0.43) | ALDH1A1TSHRTRIM24TRIM33ERN1 | |
| SCHEMBL3633987 | 0.74 | ERN1 (0.40) | KDM4EGAAALDH1A1SMN1; SMN2HTT | |
| SCHEMBL1093711 | 0.74 | DAO (0.56) | KDM4EGAAALDH1A1SMN1; SMN2HTT | |
| SCHEMBL30712834 | 0.74 | DAO (0.56) | KDM4EGAAALDH1A1SMN1; SMN2HTT | |
| SCHEMBL26932454 | 0.74 | KDM4E (0.39) | KDM4EGAAALDH1A1SMN1; SMN2HTT | |
| SCHEMBL6521130 | 0.74 | HPGD (0.57) | KDM4EALDH1A1TSHRHPGDERN1 | |
| SCHEMBL14337187 | 0.74 | ALDH1A1 (0.39) | KDM4EGAAALDH1A1SMN1; SMN2HTT | |
| SCHEMBL6517379 | 0.73 | XDH (0.50) | KDM4EGAAALDH1A1ERN1LMNA | |
| SCHEMBL19705440 | 0.72 | KDM4E (0.42) | KDM4EGAAALDH1A1SMN1; SMN2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114891063-B | Liquid phase synthesis method of palmitoyl tripeptide-1 | 浙江湃肽生物股份有限公司 | 2023-06-13 | — | — | CN | claimed |
| CN-114891063-A | Liquid phase synthesis method of palmitoyl tripeptide-1 | 浙江湃肽生物股份有限公司 | 2022-08-12 | — | — | CN | claimed |
| CN-114891063-B | Liquid phase synthesis method of palmitoyl tripeptide-1 | 浙江湃肽生物股份有限公司 | 2023-06-13 | — | — | CN | disclosed |
| CN-114891063-B | Liquid phase synthesis method of palmitoyl tripeptide-1 | 浙江湃肽生物股份有限公司 | 2023-06-13 | — | — | CN | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| CN-114891063-A | Liquid phase synthesis method of palmitoyl tripeptide-1 | 浙江湃肽生物股份有限公司 | 2022-08-12 | — | — | CN | disclosed |
| CN-114891063-A | Liquid phase synthesis method of palmitoyl tripeptide-1 | 浙江湃肽生物股份有限公司 | 2022-08-12 | — | — | CN | disclosed |
| US-8314098-B2 | Pyrazolo-pyrimidine compounds | AJINOMOTO CO., INC. (JP) | 2012-11-20 | — | — | US | disclosed |
| US-20110294792-A1 | PURINE DERIVATIVES AS KINASE INHIBITORS | ELI LILLY AND COMPANY (US) | 2011-12-01 | — | — | US | disclosed |
| US-20110294781-A1 | PYRAZOLO-PYRIMIDINE COMPOUNDS | AJINOMOTO CO., INC. (JP) | 2011-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110294781-A1 | PYRAZOLO-PYRIMIDINE COMPOUNDS | IL23R, IL2, IL17A | KDM4E 4325/4885GAA 2272/4885ALDH1A1 1291/4885 |
| US-20110294792-A1 | PURINE DERIVATIVES AS KINASE INHIBITORS | PNP, ADK, NME2 | KDM4E 1308/4885GAA 2654/4885ALDH1A1 1688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.